Advertisement

Long-Term Anticoagulant Treatment After Acute Myocardial Infarction

  • A. W. Broekmans
  • E. A. Loeliger

Abstract

The results of the Dutch Sixty Plus Reinfarction Study revived the discussion on the effectiveness of long-term oral anticoagulation after myocardial infarction (1,2). This study showed that adequately maintained and sufficiently intensive oral anticoagualtion has a beneficical effect especially on the rate of fatal and nonfatal reinfarction, but also on mortality (1).

Keywords

International Normalize Ratio Anticoagulant Therapy Oral Anticoagulation Anticoagulant Treatment Oral Anticoagulant Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980; ii:989–94.Google Scholar
  2. 2.
    Mitchell JRA. Anticoagulants in coronary heart disease — retrospect and prospect. Lancet 1981; i: 257–62.CrossRefGoogle Scholar
  3. 3.
    Gorlin R, Fuster V, Ambrose JA. Anatomic-physiologic links between acute coronary syndromes. Circulation 1986; 74: 6–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. Assessment of short-term anticoagulant administration after cardiac infarction. Br Med J 1969; 1:335–42.CrossRefGoogle Scholar
  5. 5.
    International Anticoagulant Review Group. Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction. Lancet 1970; i: 203–9.Google Scholar
  6. 6.
    Merskey C, Drapkin A. Long-term anticoagulant therapy after myocardial infarction. JAMA 1974; 230:208–9.PubMedCrossRefGoogle Scholar
  7. 7.
    May GS, Eberlein KA, Furberg C.D, et al. Secondary prevention after myocardial infarction: a review of long-term trials. Prog Cardiovasc Dis 1982; 24:331–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Loeliger EA. The optimal therapeutic range in oral anticoagulation: History and proposal. Thromb Haemost 1979; 42:1141–52.PubMedGoogle Scholar
  9. 9.
    International Committee for Standardization in Haematology and International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 1985; 53:155–6.Google Scholar
  10. 10.
    Loeliger EA. Anticoagulant therapy in acute myocardial infarction. Am Heart J 1985; 110:1322–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Dalen JE, Hirsh J. American College of Chest Physicians and the National Heart, Lung, and Blood Institue National Conference on Antithrombotic Therapy. Arch Intern Med 1986; 146:462–72.CrossRefGoogle Scholar
  12. 12.
    Loeliger EA, Van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost 1985; 53:148–54.PubMedGoogle Scholar
  13. 13.
    Poller L. Therapeutic ranges in anticoagulant administration. Br Med J 1985; 290: 1683–6.CrossRefGoogle Scholar
  14. 14.
    Loeliger EA, Poller L, Samama M, et al. Questions and answers on prothrombin time standardization in oral anticoagulant control. Thromb Haemost 1985; 54:515–7.PubMedGoogle Scholar
  15. 15.
    Hirsh J. Effectiveness of anticoagulants. Sem Thromb Hemost 1986; 12:21–37.CrossRefGoogle Scholar
  16. 16.
    Goldberg RJ, Gore JM, Dalen JE, Alpert JS. Long-term anticoagulant therapy after acute myocardial infarction. Am Heart J 1985; 109:616–22.PubMedCrossRefGoogle Scholar
  17. 17.
    Leizorovicz A, Boissel JP. Oral anticoagulant in patients surviving myocardial infarction. A new approach to old data. Eur J Clin Pharmacol 1983; 24:333–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. An assessment of long-term anticoagulant administration after cardiac infarction. Second report. Br Med J 1964; 2: 837–43.CrossRefGoogle Scholar
  19. 19.
    Ebert RV; Borden CW, Hipp HR, et al. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration Cooperative Trial. JAMA 1969; 207:2263–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Breddin K, Loew D, Lechner K, et al. The German-Austrian Aspirin Trial: A comparison of acetylsalicylic acid, placebo, and phenpro-coumon in secondary prevention of myocardial infarction. Circulation 1980; 62 (suppl. V): V63–V72.Google Scholar
  21. 21.
    Breddin K, Loew D, Lechner K, et al. Secondary prevention of myocardial infarction: A comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis 1980; 9:325–44.PubMedGoogle Scholar
  22. 22.
    Bjerkelund C.J. The effect of long-term treatment with dicoumarol in myocardial infarction. Acta Med Scand 1957; 158 (Suppl. 330): 13–212.Google Scholar
  23. 23.
    Loeliger EA, Hensen A, Kroes F, et al. A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 1967; 182:549–66.PubMedCrossRefGoogle Scholar
  24. 24.
    Meuwissen OJAT, Vervoorn AC, Cohen O, et al. Double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 1969; 186:361–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Sørensen OH, Friis T, Jørgensen AW, et al. Anticoagulant treatment of acute coronary thrombosis. Acta Med Scand 1969; 185:65–72.PubMedCrossRefGoogle Scholar
  26. 26.
    MacMillan RL, Brown KGW, Watt DL. Long-term anticoagulant therapy after myocardial infarction. Can Med Assoc J 1960; 83:567–70.PubMedGoogle Scholar
  27. 27.
    Harvald B, Hilden T, Lund E. Long-term anticoagulant therapy after myocardial infarction. Lancet 1962; ii:626–30.CrossRefGoogle Scholar
  28. 28.
    Conrad LL, Kyriacopoulos JD, Wiggins CW, Honinck GL. Preventon of recurrences of myocardial infarction. Arch Intern Med 1964; 114:348–58.PubMedCrossRefGoogle Scholar
  29. 29.
    Lovell RHH, Denborough MA, Nestel PJ, et al. A controlled trial of long-term treatment with anticoagulant after myocardial infarction in 412 male patients. Med J Aust 1967; 2:97–104.PubMedGoogle Scholar
  30. 30.
    Seaman AJ, Griswold HE, Beaume RB, Ritzman L. Long-term anticoagulant prophylaxis after myocardial infarction. N Engl J Med 1969; 281: 115–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Ritland S, Lygren T. Comparison of efficacy of 3 and 12 months’ anticoagulant therapy after myocardial infarction. Lancet 1969; i:122–4.CrossRefGoogle Scholar
  32. 32.
    Sixty Plus Reinfarction Study Research Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1982;1:64–8.Google Scholar
  33. 33.
    Hull R, Hirsh J, Jay R, et al. Different intensities of anticogulation in the long-term treatment of proximal venous thrombosis. N Engl J Med 1982; 307:1676–81.PubMedCrossRefGoogle Scholar
  34. 34.
    Whisnant JP, Cartlidge NEF, Elveback LR. Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence — a population study. Ann Neurol 1978; 3:107–15.PubMedCrossRefGoogle Scholar
  35. 35.
    Furlan AJ, Whisnant JP, Elveback LR. The decreasing incidence of primary intracerebral hemorrhage: A population study. Ann Neurol 1979; 5:367–73.PubMedCrossRefGoogle Scholar
  36. 36.
    Wintzen AR, De Jonge H, Loeliger EA, Bots GTAM. The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study. Ann Neurol 1984; 16:553–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Kase CS, Robinson RK, Stein RW, et al. Anticoagulant — related intracerebral hemorrhage. Neurology 1985; 35:943–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Loeliger EA, Van Dijk-Wierda CA, Van den Besselaar AMHP, et al. Anticoagulant control and the risk of bleeding. In: Anticoagulants and Myocardial Infarction: A Reappraisal. Ed. TW Meade. John Wiley and Sons Ltd, Chichester 1984; 135–77.Google Scholar
  39. 39.
    Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med 1984; 144: 1966–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Wright IS, Marple CD, Beck DF. Anticoagulant therapy of coronary thrombosis with myocardial infarction. JAMA 1948; 138: 1074–99.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • A. W. Broekmans
    • 1
  • E. A. Loeliger
    • 1
  1. 1.Department of HematologyUniversity Hospital Leiden and Leiden Thrombosis Centrethe Netherlands

Personalised recommendations